THYROCARE cmp 815.this stock only for study porpose and chart analysis.because it already breaked out.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
15.85 INR
707.60 M INR
5.72 B INR
15.25 M
About THYROCARE TECH LTD
Sector
Industry
CEO
Rahul Franklin Guha
Website
Headquarters
Navi Mumbai
Founded
1996
ISIN
INE594H01019
FIGI
BBG00BT3H614
Thyrocare Technologies Ltd. engages in provison of indepedent diagnostic and pathological laboratory services. It operates through the following segments: Diagnostic Testing Services, Imaging Services and Others. The Imaging Services segment represents PET-CT scan and sale of radio pharmaceuticals used in imaging services. The Others segment represents trading and other related business activities. The company was founded by A. Velumani in 1996 and is headquartered in Navi Mumbai, India.
Thyrocare Technologies Ltd view for Intraday 17th October #THYROThyrocare Technologies Ltd view for Intraday 17th October #THYROCARE
Resistance 890. Watching above 894 for upside movement...
Support area 880. Below ignoring upside momentum for intraday
Support 880..Watching below 879 for downside movement...
Resistance area 890....
Above ignoring downside mov
50 SMA Rising - Positional TradeDisclaimer: I am not a Sebi registered adviser.
This Idea is publish purely for educational purpose only before investing in any stocks please take advise from your financial adviser.
Its 50 SMA Rising Strategy. Suitable for Positional Trading Initial Stop loss lowest of last 2 candles and keep tra
THYROCARE 1WThere might be a retest at the 800 level, and then the momentum could start.
I'm not a SEBI-registered analyst. All posts and levels shared are just for educational purposes. I'm not responsible for any losses or profits. No claims, all rights reserved.
Thyrocare TechNSE:THYROCARE Weekly chart shows accumulation completed with rounding bottom formation with buyers and trend.
Thyrocare #thyrocare
Round bottom pattern in making
Making higher high in recent time
Fundamentally strong company
Targets 2x around 1600++
portfolio stock
Timeframe medium to long
6 months to 1 year
"U" Shape Pattern* 6 Month Tight Consolidation touched on Support & Resistance multiple times, and breakout
* 2 Year Consolidation touched on resistance multiple times trend line Year May-22 TO July-24.
* Expected To reach at the next level. Price level - 1440.
Triangle BreakoutThyrocare Beautiful Traingle Breakout in weekly timeframe. Trail stoploss with super trend
#Thyrocare#Thyrocare #Stocks company has posted impressive results, stock is also forming a symmetrical triangle pattern, let's see. It is near 0 Line. It is going to burst. CMP 649, My Target for the stock is 680/720, stop loss DCB 630. Good risk reward for short term.
Strong Technical Buy Thyrocare cmp 602, target 690 sl 565The stock seems to have bottomed out and ready to make new highs so our first target is the initial resistance of 690 and later on it can shoot to 750-800 range.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of THYROCARE is 957.45 INR — it has decreased by −1.33% in the past 24 hours. Watch THYROCARE TECHNOLOGIES LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange THYROCARE TECHNOLOGIES LIMITED stocks are traded under the ticker THYROCARE.
THYROCARE stock has fallen by −0.98% compared to the previous week, the month change is a 10.17% rise, over the last year THYROCARE TECHNOLOGIES LIMITED has showed a 67.87% increase.
We've gathered analysts' opinions on THYROCARE TECHNOLOGIES LIMITED future price: according to them, THYROCARE price has a max estimate of 1,040.00 INR and a min estimate of 975.00 INR. Watch THYROCARE chart and read a more detailed THYROCARE TECHNOLOGIES LIMITED stock forecast: see what analysts think of THYROCARE TECHNOLOGIES LIMITED and suggest that you do with its stocks.
THYROCARE reached its all-time high on Jun 25, 2021 with the price of 1,465.90 INR, and its all-time low was 406.65 INR and was reached on Jul 31, 2019. View more price dynamics on THYROCARE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
THYROCARE stock is 3.20% volatile and has beta coefficient of 0.40. Track THYROCARE TECHNOLOGIES LIMITED stock price on the chart and check out the list of the most volatile stocks — is THYROCARE TECHNOLOGIES LIMITED there?
Today THYROCARE TECHNOLOGIES LIMITED has the market capitalization of 50.72 B, it has decreased by −1.28% over the last week.
Yes, you can track THYROCARE TECHNOLOGIES LIMITED financials in yearly and quarterly reports right on TradingView.
THYROCARE TECHNOLOGIES LIMITED is going to release the next earnings report on Jan 31, 2025. Keep track of upcoming events with our Earnings Calendar.
THYROCARE net income for the last quarter is 266.70 M INR, while the quarter before that showed 241.70 M INR of net income which accounts for 10.34% change. Track more THYROCARE TECHNOLOGIES LIMITED financial stats to get the full picture.
Yes, THYROCARE dividends are paid annually. The last dividend per share was 18.00 INR. As of today, Dividend Yield (TTM)% is 1.88%. Tracking THYROCARE TECHNOLOGIES LIMITED dividends might help you take more informed decisions.
THYROCARE TECHNOLOGIES LIMITED dividend yield was 3.04% in 2023, and payout ratio reached 134.66%. The year before the numbers were 4.19% and 147.70% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 24, 2024, the company has 1.69 K employees. See our rating of the largest employees — is THYROCARE TECHNOLOGIES LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. THYROCARE TECHNOLOGIES LIMITED EBITDA is 1.56 B INR, and current EBITDA margin is 24.98%. See more stats in THYROCARE TECHNOLOGIES LIMITED financial statements.
Like other stocks, THYROCARE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade THYROCARE TECHNOLOGIES LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So THYROCARE TECHNOLOGIES LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating THYROCARE TECHNOLOGIES LIMITED stock shows the buy signal. See more of THYROCARE TECHNOLOGIES LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.